"How can SCAI and industry partners increase adherence and educate interventionalists on optimal medical therapy?"

Sammy Elmariah; Sunil V Rao; Cindy L Grines; Kirk N Garratt; Ronald P Caputo; Timothy D Henry; Srihari S Naidu; members of the SCAI 2018 Think Tank Consortium; Narinder Bhalla; Bill Gagliardi; John Venditto

doi:10.1002/ccd.27911

"How can SCAI and industry partners increase adherence and educate interventionalists on optimal medical therapy?"

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):305-308. doi: 10.1002/ccd.27911. Epub 2018 Nov 4.

Affiliations

¹ Massachusetts General Hospital, Boston, MA, United States.
² Duke University Hospital, Durham, Virginia, United States.
³ Northwell Health System, Manhasset, NY, United States.
⁴ Christiana Care Health System, Newark, DE, United States.
⁵ St. Joseph's Cardiovascular Specialists, Syracuse, New York, United States.
⁶ Cedars-Sinai Heart Institute, Los Angeles, CA, United States.
⁷ Westchester Medical Center, Valhalla, NY, United States.
⁸ AstraZeneca, Chadds Ford, PA, United States.
⁹ Janssen Pharmaceuticals, Raritan NJ, United States.
¹⁰ AstraZeneca, Wilmington, DE, United States.

PMID: 30393971
DOI: 10.1002/ccd.27911

No abstract available

Keywords: acute myocardial infarction; anticoagulants/antithrombins; antiplate therapy; coronary artery disease; drugs/pharmacotherapy; evidence-based medicine.

Publication types

Review

MeSH terms

Attitude of Health Personnel
Cardiologists / education*
Cardiologists / psychology
Cardiovascular Agents / therapeutic use*
Congresses as Topic
Education, Medical, Continuing*
Guideline Adherence
Health Care Sector*
Health Knowledge, Attitudes, Practice
Heart Diseases / diagnostic imaging
Heart Diseases / therapy*
Humans
Interdisciplinary Communication
Medication Adherence*
Practice Guidelines as Topic
Practice Patterns, Physicians'*
Radiologists / education*
Radiologists / psychology
Societies, Medical*
Stakeholder Participation

Substances

Cardiovascular Agents